The IFITM Proteins Inhibit HIV-1 Infection

被引:334
|
作者
Lu, Jennifer [1 ,2 ]
Pan, Qinghua [1 ]
Rong, Liwei [1 ]
Liu, Shan-Lu [3 ,4 ]
Liang, Chen [1 ,2 ,3 ]
机构
[1] McGill Univ, Jewish Gen Hosp, McGill AIDS Ctr, Lady Davis Inst, Montreal, PQ H3T 1E2, Canada
[2] McGill Univ, Dept Med, Montreal, PQ H3A 2B4, Canada
[3] McGill Univ, Dept Microbiol & Immunol, Montreal, PQ H3A 2B4, Canada
[4] Univ Missouri, Dept Mol Microbiol & Immunol, Bond Life Sci Ctr, Columbia, MO 65211 USA
基金
加拿大健康研究院;
关键词
IMMUNODEFICIENCY-VIRUS TYPE-1; STABLE SIGNAL PEPTIDE; WEST NILE VIRUS; INTERFERON-ALPHA; T-CELLS; IFN-ALPHA; ENVELOPE GLYCOPROTEIN; DISTINCT MECHANISMS; REPLICATION INVITRO; ANTIVIRAL RESPONSE;
D O I
10.1128/JVI.01531-10
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Type I interferon protects cells from virus infection through the induction of a group of genes collectively named interferon-stimulated genes (ISGs). In this study, we utilized short hairpin RNA (shRNA) to deplete ISGs in SupT1 cells in order to identify ISGs that suppress the production of human immunodeficiency virus type 1 (HIV-1). Among the ISG candidates thus identified were interferon-induced transmembrane (IFITM) proteins, including IFITM1, IFITM2, and IFITM3, that potently inhibit HIV-1 replication at least partially through interfering with virus entry. Further mutagenesis analysis shows that the intracellular region, rather than the N- and C-terminal extracellular domains, is essential for the antiviral activity of IFITM1. Altogether, these data suggest that the IFITM proteins serve as important components of the innate immune system to restrict HIV-1 infection.
引用
收藏
页码:2126 / 2137
页数:12
相关论文
共 50 条
  • [41] Membrane-associated RING-CH (MARCH) 1 and 2 are other members of MARCH proteins that inhibit HIV-1 infection
    Yao, W.
    Tada, T.
    Zhang, Y.
    Fujita, H.
    Yamaoka, S.
    Tokunaga, K.
    JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2017, 20 : 49 - 49
  • [42] Resistance of Transmitted Founder HIV-1 to IFITM-Mediated Restriction
    Foster, Toshana L.
    Wilson, Harry
    Iyer, Shilpa S.
    Coss, Karen
    Doores, Katie
    Smith, Sarah
    Kellam, Paul
    Finzi, Andres
    Borrow, Persephone
    Hahn, Beatrice H.
    Neil, Stuart J. D.
    Cell Host & Microbe, 2016, 20 (04) : 429 - 442
  • [43] Mixed cryoglobulinemia in HIV-1 infection: The role of HIV-1
    Dimitrakopoulos, AN
    Kordossis, T
    Hatzakis, A
    Moutsopoulos, HM
    ANNALS OF INTERNAL MEDICINE, 1999, 130 (03) : 226 - 230
  • [44] A case of HIV-1 superinfection in chronic HIV-1 infection
    Longwill, S.
    Hourihan, M.
    Apea, V.
    HIV MEDICINE, 2010, 11 : 36 - 36
  • [45] DING proteins, their biochemical and structural properties, and their ability to inhibit HIV-1 replication DISCUSSION
    Montagnier, Luc
    Le Gall, Jean-Yves
    Adolphe, Monique
    Michel, Francois-Bernard
    BULLETIN DE L ACADEMIE NATIONALE DE MEDECINE, 2012, 196 (03): : 704 - 704
  • [46] SnapShot: HIV-1 proteins
    Swanson, Chad M.
    Malim, Michael H.
    CELL, 2008, 133 (04)
  • [47] Profiling of placental macrophages cytosolic proteins after HIV-1 infection
    Montalvo, CL
    Anderson, E
    Rodriguez, E
    Garcia, V
    Melendez-Guerrero, LM
    JOURNAL OF LEUKOCYTE BIOLOGY, 2005, : 41 - 42
  • [48] Role of Microtubules and Microtubule-Associated Proteins in HIV-1 Infection
    Dharan, Adarsh
    Campbell, Edward M.
    JOURNAL OF VIROLOGY, 2018, 92 (16)
  • [49] REGULATORY PROTEINS OF HIV-1
    CULLEN, BR
    JOURNAL OF CELLULAR BIOCHEMISTRY, 1993, : 5 - 5
  • [50] Potential treatment of HIV infection using miRNA-siRNA hybrids to inhibit HIV-1 replication
    Yam, P.
    Lo, H.
    Marcovecchio, P. M.
    Chang, T.
    Zaia, J. A.
    Yee, J.
    TRANSFUSION, 2007, 47 (03) : 209A - 209A